Medix Inc. (TYO:331A)
500.00
-20.00 (-3.85%)
Feb 13, 2026, 3:30 PM JST
Medix Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 4,128 | 3,771 | 2,780 | 2,363 | 1,778 | 1,393 |
Cash & Short-Term Investments | 4,128 | 3,771 | 2,780 | 2,363 | 1,778 | 1,393 |
Cash Growth | 48.49% | 35.65% | 17.65% | 32.89% | 27.64% | 20.88% |
Receivables | 2,171 | 2,226 | 2,292 | 2,242 | 2,227 | 1,898 |
Inventory | - | - | - | - | 91.43 | 15.7 |
Prepaid Expenses | - | 103 | 98 | 97 | - | - |
Other Current Assets | 142 | 2 | 5 | 13 | 58.9 | 163.69 |
Total Current Assets | 6,441 | 6,102 | 5,175 | 4,715 | 4,155 | 3,471 |
Property, Plant & Equipment | 105 | 114 | 132 | 111 | 111.03 | 122.85 |
Long-Term Investments | 478 | 177 | 446 | 430 | - | - |
Other Intangible Assets | 23 | 22 | 34 | 40 | 41.18 | 52.34 |
Long-Term Deferred Tax Assets | - | 235 | 94 | 112 | - | - |
Other Long-Term Assets | 1 | 2 | 1 | 1 | 830.03 | 1,172 |
Total Assets | 7,048 | 6,669 | 5,903 | 5,431 | 5,137 | 4,818 |
Accounts Payable | - | - | - | - | 2,071 | 1,599 |
Accrued Expenses | 66 | 176 | 210 | 270 | - | - |
Short-Term Debt | - | - | - | - | 299.5 | 300 |
Current Portion of Long-Term Debt | 192 | 95 | 229 | 244 | - | - |
Current Portion of Leases | - | 2 | 2 | - | - | - |
Current Income Taxes Payable | 2,051 | 2,393 | 2,514 | 2,210 | - | - |
Other Current Liabilities | 301 | 166 | 170 | 238 | 867.02 | 635.48 |
Total Current Liabilities | 2,610 | 2,832 | 3,125 | 2,962 | 3,237 | 2,534 |
Long-Term Debt | 675 | 16 | 111 | 252 | 169 | 710.7 |
Long-Term Leases | - | 8 | 11 | - | - | - |
Pension & Post-Retirement Benefits | 514 | 532 | 488 | 476 | - | - |
Other Long-Term Liabilities | 10 | 13 | 11 | 12 | 375.18 | 423.49 |
Total Liabilities | 3,809 | 3,401 | 3,746 | 3,702 | 3,782 | 3,669 |
Common Stock | 259 | 259 | 75 | 75 | 1,356 | 1,150 |
Additional Paid-In Capital | 249 | 262 | 78 | 78 | - | - |
Retained Earnings | 2,960 | 2,762 | 2,018 | 1,575 | - | - |
Treasury Stock | -248 | -16 | -16 | - | - | - |
Comprehensive Income & Other | 19 | 1 | 2 | 1 | - | - |
Shareholders' Equity | 3,239 | 3,268 | 2,157 | 1,729 | 1,356 | 1,150 |
Total Liabilities & Equity | 7,048 | 6,669 | 5,903 | 5,431 | 5,137 | 4,818 |
Total Debt | 867 | 121 | 353 | 496 | 468.5 | 1,011 |
Net Cash (Debt) | 3,261 | 3,650 | 2,427 | 1,867 | 1,310 | 382.4 |
Net Cash Growth | 34.36% | 50.39% | 30.00% | 42.56% | 242.49% | - |
Net Cash Per Share | 399.98 | 466.91 | 321.73 | 246.31 | - | - |
Filing Date Shares Outstanding | 7.54 | 7.6 | 7.54 | 7.58 | - | - |
Total Common Shares Outstanding | 7.54 | 7.6 | 7.54 | 7.58 | - | - |
Working Capital | 3,831 | 3,270 | 2,050 | 1,753 | - | - |
Book Value Per Share | 429.71 | 430.24 | 285.94 | 228.10 | - | - |
Tangible Book Value | 3,216 | 3,246 | 2,123 | 1,689 | - | - |
Tangible Book Value Per Share | 426.66 | 427.34 | 281.43 | 222.82 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.